HomeCompaniesProfile

Indee Labs

Enabling T cell immunotherapy discovery, development and manufacturing 


Company Size

1 - 5 employees

Year Founded

2015


About Indee Labs

Intracellular delivery is the most problematic step in T cell immunotherapy discovery, development and manufacturing. Indee Labs is developing a non-viral intracellular delivery system based on microfluidic vortex shedding (µVS) to rapidly deliver nucleic acids, proteins and gene editing complexes to patient and donor T cells with minimal perturbation.

Founders & Key People

Ryan Pawell

Ryan Pawell

Founder/CEO, Indee Labs

Share This Profile

More Companies

Satsuma

Reliable blockchain indexing & querying for web3 engineering teams.

Stable

A virtual address + mailbox for business

FundersClub

Online VC

Eduflow

Create and run collaborative online learning experiences.

Flowdash

Quickly build internal tools for your ops team's manual workflows

Revolve Surgical

Surgical robotics for every operating room

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2026 BEAMSTART. All Rights Reserved.